Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis-Reference-Cited by-同舟云学术

Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis

Published:2020-01-15 Issue:2 Volume:59 Page:229-233
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Miyawaki Hiroshi¹,Kioka Hidetaka¹,Sato Kazuaki²,Kurashige Masako²,Ozawa Takayuki³,Shibayama Hirohiko³,Hikoso Shungo¹,Morii Eiichi²,Yamauchi-Takihara Keiko¹⁴,Sakata Yasushi¹

Affiliation:

1. Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Japan

2. Department of Pathology, Osaka University Graduate School of Medicine, Japan

3. Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Japan

4. Health Care Center, Osaka University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/2/59_3528-19/_pdf

Reference15 articles.

1. 1. Tefferi A. Myeloproliferative neoplasms: a decade of discoveries and treatment advances. Am J Hematol 91: 50-58, 2016.

2. 2. Tefferi A. Primary myelofibrosis: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 91: 1262-1271, 2016.

3. 3. Harrison C, Kiladjian JJ, Al-Ali HK, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med 366: 787-798, 2012.

4. 4. Tabarroki A, Lindner DJ, Visconte V, et al. Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis. Leukemia 28: 1486-1493, 2014.

5. 5. Yamauchi-Takihara K, Kishimoto T. A novel role for STAT3 in cardiac remodeling. Trends Cardiovasc Med 10: 298-303, 2000.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications;Reviews in Cardiovascular Medicine;2024-03-05

2. Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study;American Journal of Respiratory and Critical Care Medicine;2023-09-01

3. Promising Use of Filgotinib in Patients Affected by Systemic Sclerosis: Preliminary Data From a Monocentric, Prospective, Open-label Study;2023-07-05

4. Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer;Signal Transduction and Targeted Therapy;2023-05-19

5. Probing the Neuro-psychological Changes Observed with the Administration of COVID-19 Drugs;Current Topics in Medicinal Chemistry;2023-01